Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05997693 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

One-Month DAPT in CABG Patients

Study acronym: ODIN
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 1 of 22 sitesv6
  2. Study sites: 23 to 22v5
  3. Study sites: 12 to 23v4
  4. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Start date changed from estimate of Oct 2024 to Aug 15, 2024
    • Interventions: Ticagrelor 90 MG (Drug), Ticagrelor placebo (Drug) to Low-dose aspirin (Drug), Ticagrelor 90 MG (Drug)
    • Site details revised at 12 of 12 sites
    • Study description shortened, about 1 word
  5. Start date: Jan 2024 to Oct 2024v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to compare the effect of ticagrelor plus low-dose aspirin versus low-dose aspirin alone in patients with chronic coronary disease undergoing coronary artery bypass grafting.
Trial Details
NCT Number NCT05997693
Lead Sponsor Weill Medical College of Cornell University
Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions
(from sponsor)		 Chronic Coronary Disease
Enrollment 700 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov